Influencing drug molecule and product design using chemical stability knowledge.

• In: Poster Presentation
• At: Stockholm (Sweden) (2017)
• Type: Poster
• Poster code: P-C-021-Tuesday
• By: OTTOSSON, Jenny (AstraZeneca, Pharmaceutical Sciences, Mölndal, Sweden)
• Co-author(s): Jenny Ottosson: Pharmaceutical Sciences, AstraZeneca, Mölndal, Sweden
  Carolyn Stevenson: Pharmaceutical Sciences, AstraZeneca, Mölndal, Sweden
  Karin Carlsson: Pharmaceutical Sciences, AstraZeneca, Mölndal, Sweden
  Angela Ku: Pharmaceutical Sciences, AstraZeneca, Mölndal, Sweden
  
• Abstract:

  Backgrounds

  Using experimental data and knowledge of drug molecule characteristics can influence product design, identify risks and any needed mitigation. 

  Aims

  In the very early stages of drug development however it can sometimes be hard to see where and how to influence the molecule design based on potential drug product stability concerns, which
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login